For the Inventor, By the Inventor

Enter assignee name

Shanghai, China

Shanghai Pharmaceuticals Holding Co., Ltd.

USPTO Granted Patents = 11

EPO Patents = 8

Trademarks = 6

Forward Citations = 5

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Guangxin Xia (9 out of 11 patents)

Toru Iijima (5 out of 15 patents)

Jingkang Shen (4 out of 18 patents)

4. Yanjun Liu (4 out of 9 patents)

5. Jianshu Xie (4 out of 5 patents)

6. Hiroshi Sugama (4 out of 8 patents)

7. Takayuki Kawaguchi (3 out of 43 patents)

8. Yu Mao (3 out of 8 patents)

9. Miki Hirai (3 out of 4 patents)

10. Qian Wang (2 out of 12 patents)

11. Biao Yu (2 out of 6 patents)

12. Chen Shi (2 out of 2 patents)

13. Xiong Zhai (2 out of 2 patents)

14. Hui Ge (2 out of 3 patents)

15. Xuemei Liao (2 out of 2 patents)

11 patents: Sort by Forward Citations

1. 11643428 - Therapeutic drug for neurodegenerative disease and application thereof (2023-05-09),

2. 11578092 - Compound for preventing or treating neurodegenerative disease and application thereof (2023-02-14),

3. 10988476 - Substituted pyrimidines as cyclin-dependent kinase inhibitors (2021-04-27),

4. 10870627 - Salt of quinazoline derivative, preparation method therefor and application thereof (2020-12-22),

5. 10828305 - Nitrogenous heterocyclic compound, preparation method, intermediate, composition and use (2020-11-10),

6. 10662186 - Substituted pyrimidines as cyclin-dependent kinase inhibitors (2020-05-26),

7. 10519150 - Salts of morpholine derivative, crystal forms thereof, processes for producing the same, pharmaceutical compositions including the same, and use thereof (2019-12-31),

8. 10155731 - Nitrogen-containing saturated heterocyclic compound (2018-12-18),

9. 9556159 - Renin inhibitor (2017-01-31),

10. 9278944 - Nitrogen-containing saturated heterocyclic compound (2016-03-08),

11. 8975252 - Morpholine derivative (2015-03-10),

Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) is a leading Chinese company engaged in the distribution, manufacturing, research, and development of pharmaceutical products. With a focus on promoting public health, SPH offers a comprehensive range of medical and healthcare solutions. The company consistently improves its products and services to meet the evolving needs of the market and ensure customer satisfaction. For more information, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

11 Patents

#206 in Shanghai

#2,258 in China

#50,205 in the World

Shanghai, China

Shanghai Pharmaceuticals Holding Co., Ltd.

Forward Citations = 5

41 inventors:

Guangxin Xia (9 out of 11 patents)

Toru Iijima (5 out of 15 patents)

Jingkang Shen (4 out of 18 patents)

4. Yanjun Liu (4 out of 9 patents)

5. Jianshu Xie (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…